Strategic partnership agreement integrates Sonrai’s AI data management platform “Sonrai Discovery” into SmartLabs’ advanced laboratory infrastructure
SmartLabs and Sonrai Analytics (Sonrai) announced a global strategic partnership aimed at integrating Sonrai’s next-generation AI capabilities directly into SmartLabs’ network of advanced research centers. Under this agreement, SmartLabs will offer Sonrai’s AI-based analytics platform, Sonrai Discovery, to its member companies. Both companies will also develop new laboratory informatics and custom AI applications that integrate experimental and infrastructure data to predict scientific outcomes and accelerate discoveries, exclusively for SmartLabs’ network.
Sonrai’s cloud-based AI platform for precision medicine enables biotech and pharma teams to optimize diagnostic processes, improve molecular profiling, and accelerate biomarker discovery by integrating imaging and omics data in a secure data ecosystem. By integrating these unique capabilities into SmartLabs’ five managed research centers, member companies gain access not only to the Sonrai Discovery Platform but also to exclusive informatics and AI applications available only through SmartLabs, enabling more powerful decision-making.
For SmartLabs, a leading provider of flexible laboratory infrastructure and operational services solutions, the partnership represents a bold expansion of its model to meet the growing demand for AI-powered research solutions. By combining infrastructure, operational, and scientific expertise with Sonrai’s advanced analytics, SmartLabs equips its members with advanced analytical tools to manage complex data at scale and accelerate the discovery of meaningful patterns and biomarkers.
Also Read: Altasciences & Evidence Matters partner on AI for regulatory docs
“We live in the age of data, and AI is what unlocks its true value,” said Brian Taylor, CEO of SmartLabs . “I’m thrilled about this partnership as it allows us to harness this newfound power to fundamentally improve human health in the future.”
“At Sonrai, our mission is to drive the most important breakthroughs in precision medicine through connected data and collaborative science. We are delighted to partner with SmartLabs to bring the power of AI and advanced analytics directly to their member companies,” said Prof. Darragh McArt , founder and CEO of Sonrai . “By delivering faster insights and a deeper understanding of complex datasets, we are helping to accelerate breakthrough discoveries and the development of next-generation personalized therapeutics.”
This collaboration underscores SmartLabs’ mission to advance science and the discovery of life-saving therapies. Providing our members with world-class support services and cutting-edge research tools at every stage of research and development is a core component of the company’s model. By adding Sonrai‘s cutting-edge capabilities, SmartLabs members can focus their resources on driving innovation across multiple modalities, therapeutic areas, and stages of development—thus delivering transformative treatments to patients faster.
Source: PRNewswire